Ovarian Cancer - Masters Of Hematology And Oncology: David Alberts, MD

Main Category: Ovarian Cancer
Also Included In: Cancer / Oncology
Article Date: 30 Apr 2009 - 4:00 PDT

email to a friend   printer friendly   view / write opinions

Throughout his diverse career, Dr. David Alberts has focused on science and its effect on quality of life. "Looking back on my career, I am most proud of helping the wonderful women who suffer from ovarian cancer and the progress we have made in reducing the burden of skin care in the Southwest," said the Tucson-based director of the Arizona Cancer Center.

Dr. Alberts talks about his passion for everything from pure science to cancer prevention to the true value of research in the context of patient care.

Dr. Alberts' contributions to ovarian cancer treatment are extensive. Together with the Hilary Calvert, UK, MD, Dr. Alberts was involved in the development of carboplatin for gynecologic tumor treatment and was involved in the trials at the Arizona Cancer Center. Dr. Alberts also supervised the Southwest Oncology Group and Gynecologic Oncology Group through major IP trials. "It's still a struggle . . . to get IP therapy established as an absolute for woman with stage III, optimally debulked disease. We conducted three big studies that showed a median survival improvement of more than 12 months with IP chemotherapy. But we haven't adequately trained our oncologists on how to do IP," he said

Masters of Hematology and Oncology
"David Alberts: Survival of the fittest"
Shalmali Pal
Oncology News International. Vol. 18 No. 4

Source
Cancer Network